Our results demonstrated that although the immune landscape in pediatric COVID-19 was similar to adults, MIS-C represented an exacerbated T cell activation state, particularly for CD8+ T cells, including a highly activated vascular patrolling CD8+ T cell subset. The gene discussed is CD8A; the disease is COVID-19.